{
    "clinical_study": {
        "@rank": "67297", 
        "arm_group": {
            "arm_group_label": "Escitalopram", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "An Open-label, single dosing clinical trial to investigate the pharmacokinetics and the\n      effect on ECG of escitalopram after oral administration in elderly volunteers."
        }, 
        "brief_title": "A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly Volunteers", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy subject aged 65 or older at screening\n\n          -  A body weight in the range of 50 kg (inclusive) to 90 kg (inclusive) with BMI range\n             of 19.0 to 28.0\n\n          -  subjects who decide to participate voluntarily and write a informed consent form\n\n        Exclusion Criteria:\n\n          -  subjects who have clinically significant disease of cardiovascular, respiratory,\n             renal, endocrinological, hematological, gastrointestinal, neurological(central\n             nervous system), psychiatric disorders or malignant tumor\n\n          -  Subject judged not eligible for study participation by investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122939", 
            "org_study_id": "ECTE"
        }, 
        "intervention": {
            "arm_group_label": "Escitalopram", 
            "intervention_name": "Escitalopram", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dexetimide", 
                "Citalopram"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam", 
                    "country": "Korea, Republic of", 
                    "state": "Gyounggi"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-label, Single Dosing Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram After Oral Administration in Elderly Volunteers", 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital, Seongnam, Korea", 
            "last_name": "Jae-Yong Chung, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Cmax, AUCinf, AUClast, Tmax, t1/2, CL/F", 
            "safety_issue": "No", 
            "time_frame": "pre-dose, 1, 2, 3, 4, 6, 8, 12, 24, 32, 48 h post-dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122939"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Jae Yong Chung", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "QTc interval", 
            "safety_issue": "No", 
            "time_frame": "pre-dose, 1, 4, 6, 8, 12, 24, 28, 32, 48 h post-dose"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}